Hexagon Capital Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15
| Closed | -$2.34K | – | 203 |
|
|
2025
Q1 | $2.34K | Buy |
15
+2
| +15% | +$312 | ﹤0.01% | 1359 |
|
|
2024
Q4 | $1.79K | Buy |
+13
| New | +$1.79K | ﹤0.01% | 1450 |
|
|
2023
Q2 | – | Sell |
-53
| Closed | -$5.68K | – | 1430 |
|
|
2023
Q1 | $5.68K | Sell |
53
-6
| -10% | -$643 | ﹤0.01% | 866 |
|
|
2022
Q4 | $7.21K | Hold |
59
| – | – | ﹤0.01% | 816 |
|
|
2022
Q3 | $6K | Buy |
+59
| New | +$6K | ﹤0.01% | 879 |
|